The Cell Banking Outsourcing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of cell banking outsourcing has significantly expanded recently. It was projected to increase from $11.19 billion in 2024 to $12.89 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%.
The cell banking outsourcing market is expected to rise to $22.39 billion in 2029, with a compound annual growth rate (CAGR) of 14.8%.
Download Your Free Sample of the 2025 Cell Banking Outsourcing Market Report and Uncover Key Trends Now!The drivers in the cell banking outsourcing market are:
• Rise in the prevalence of chronic diseases
• Increased number of government initiatives
• Enhanced regulatory support and guidelines
• Growth in the establishment of banking services
The cell banking outsourcing market covered in this report is segmented –
1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking
2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking
3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation
The trends in the cell banking outsourcing market are:
• Increasing adoption of cellular products is a trend in the cell banking outsourcing market.
• There is a growing demand for monoclonal antibodies.
• Uptake of stem cell therapies is a trend shaping this market.
• Dependency on cell-based therapies is also an emerging trend.
The major players in the cell banking outsourcing market are:
• LabCorp Drug Development
• SGS Life Sciences
• Lonza Group Ltd
North America was the largest region in the cell banking outsourcing market in 2023